ID CLC9A_HUMAN Reviewed; 241 AA. AC Q6UXN8; B0ZBM2; DT 30-AUG-2005, integrated into UniProtKB/Swiss-Prot. DT 05-JUL-2004, sequence version 1. DT 05-FEB-2025, entry version 142. DE RecName: Full=C-type lectin domain family 9 member A; DE AltName: CD_antigen=CD370; GN Name=CLEC9A; ORFNames=UNQ9341/PRO34046; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], SUBUNIT, PHOSPHORYLATION, SUBCELLULAR LOCATION, RP TISSUE SPECIFICITY, AND GLYCOSYLATION. RX PubMed=18408006; DOI=10.1074/jbc.m709923200; RA Huysamen C., Willment J.A., Dennehy K.M., Brown G.D.; RT "CLEC9A is a novel activation C-type lectin-like receptor expressed on RT BDCA3+ dendritic cells and a subset of monocytes."; RL J. Biol. Chem. 283:16693-16701(2008). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RX PubMed=12975309; DOI=10.1101/gr.1293003; RA Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J., RA Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., RA Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A., RA Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D., RA Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L., RA Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C., RA Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J., RA Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.; RT "The secreted protein discovery initiative (SPDI), a large-scale effort to RT identify novel human secreted and transmembrane proteins: a bioinformatics RT assessment."; RL Genome Res. 13:2265-2270(2003). RN [3] RP TISSUE SPECIFICITY, AND FUNCTION. RX PubMed=18497879; DOI=10.1172/jci34584; RA Sancho D., Mourao-Sa D., Joffre O.P., Schulz O., Rogers N.C., RA Pennington D.J., Carlyle J.R., Reis e Sousa C.; RT "Tumor therapy in mice via antigen targeting to a novel, DC-restricted C- RT type lectin."; RL J. Clin. Invest. 118:2098-2110(2008). RN [4] RP X-RAY CRYSTALLOGRAPHY (1.64 ANGSTROMS) OF 110-241, FUNCTION, DISULFIDE RP BONDS, SUBUNIT, AND MUTAGENESIS OF TRP-131 AND TRP-227. RX PubMed=22483802; DOI=10.1016/j.immuni.2012.03.009; RA Zhang J.G., Czabotar P.E., Policheni A.N., Caminschi I., Wan S.S., RA Kitsoulis S., Tullett K.M., Robin A.Y., Brammananth R., van Delft M.F., RA Lu J., O'Reilly L.A., Josefsson E.C., Kile B.T., Chin W.J., Mintern J.D., RA Olshina M.A., Wong W., Baum J., Wright M.D., Huang D.C., Mohandas N., RA Coppel R.L., Colman P.M., Nicola N.A., Shortman K., Lahoud M.H.; RT "The dendritic cell receptor Clec9A binds damaged cells via exposed actin RT filaments."; RL Immunity 36:646-657(2012). CC -!- FUNCTION: Functions as an endocytic receptor on a small subset of CC myeloid cells specialized for the uptake and processing of material CC from dead cells. Recognizes filamentous form of actin in association CC with particular actin-binding domains of cytoskeletal proteins, CC including spectrin, exposed when cell membranes are damaged, and CC mediate the cross-presentation of dead-cell associated antigens in a CC Syk-dependent manner. {ECO:0000269|PubMed:18497879, CC ECO:0000269|PubMed:22483802}. CC -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:18408006, CC ECO:0000269|PubMed:22483802}. CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:18408006}; Single- CC pass type II membrane protein {ECO:0000269|PubMed:18408006}. CC -!- TISSUE SPECIFICITY: In peripheral blood highly restricted on the CC surface of BDCA31(+) dendritic cells and on a small subset of CD14(+) CC and CD16(-) monocytes. {ECO:0000269|PubMed:18408006, CC ECO:0000269|PubMed:18497879}. CC -!- PTM: N-glycosylated. {ECO:0000269|PubMed:18408006}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; EU339276; ABZ04557.1; -; mRNA. DR EMBL; AY358265; AAQ88632.1; -; mRNA. DR CCDS; CCDS8611.1; -. DR RefSeq; NP_997228.1; NM_207345.3. DR PDB; 3VPP; X-ray; 1.64 A; A/B=110-241. DR PDBsum; 3VPP; -. DR AlphaFoldDB; Q6UXN8; -. DR SMR; Q6UXN8; -. DR BioGRID; 129557; 1. DR STRING; 9606.ENSP00000348074; -. DR UniLectin; Q6UXN8; -. DR GlyCosmos; Q6UXN8; 2 sites, No reported glycans. DR GlyGen; Q6UXN8; 2 sites. DR iPTMnet; Q6UXN8; -. DR PhosphoSitePlus; Q6UXN8; -. DR BioMuta; CLEC9A; -. DR DMDM; 73917794; -. DR MassIVE; Q6UXN8; -. DR PaxDb; 9606-ENSP00000348074; -. DR PeptideAtlas; Q6UXN8; -. DR ProteomicsDB; 67640; -. DR ABCD; Q6UXN8; 59 sequenced antibodies. DR Antibodypedia; 23221; 529 antibodies from 30 providers. DR DNASU; 283420; -. DR Ensembl; ENST00000355819.6; ENSP00000348074.1; ENSG00000197992.7. DR GeneID; 283420; -. DR KEGG; hsa:283420; -. DR MANE-Select; ENST00000355819.6; ENSP00000348074.1; NM_207345.4; NP_997228.1. DR UCSC; uc001qxa.4; human. DR AGR; HGNC:26705; -. DR CTD; 283420; -. DR DisGeNET; 283420; -. DR GeneCards; CLEC9A; -. DR HGNC; HGNC:26705; CLEC9A. DR HPA; ENSG00000197992; Tissue enhanced (brain, lymphoid tissue). DR MIM; 612252; gene. DR neXtProt; NX_Q6UXN8; -. DR OpenTargets; ENSG00000197992; -. DR PharmGKB; PA142672093; -. DR VEuPathDB; HostDB:ENSG00000197992; -. DR eggNOG; KOG4297; Eukaryota. DR GeneTree; ENSGT00940000161796; -. DR HOGENOM; CLU_049894_9_0_1; -. DR InParanoid; Q6UXN8; -. DR OMA; WDSPAPN; -. DR OrthoDB; 6337382at2759; -. DR PhylomeDB; Q6UXN8; -. DR TreeFam; TF336674; -. DR PathwayCommons; Q6UXN8; -. DR SignaLink; Q6UXN8; -. DR BioGRID-ORCS; 283420; 11 hits in 1141 CRISPR screens. DR ChiTaRS; CLEC9A; human. DR EvolutionaryTrace; Q6UXN8; -. DR GenomeRNAi; 283420; -. DR Pharos; Q6UXN8; Tbio. DR PRO; PR:Q6UXN8; -. DR Proteomes; UP000005640; Chromosome 12. DR RNAct; Q6UXN8; protein. DR Bgee; ENSG00000197992; Expressed in male germ line stem cell (sensu Vertebrata) in testis and 97 other cell types or tissues. DR GO; GO:0009986; C:cell surface; IDA:UniProtKB. DR GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell. DR GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW. DR GO; GO:0001819; P:positive regulation of cytokine production; IDA:UniProtKB. DR GO; GO:0006898; P:receptor-mediated endocytosis; IDA:UniProtKB. DR CDD; cd03593; CLECT_NK_receptors_like; 1. DR FunFam; 3.10.100.10:FF:000075; C-type lectin domain family 9 member A; 1. DR Gene3D; 3.10.100.10; Mannose-Binding Protein A, subunit A; 1. DR InterPro; IPR001304; C-type_lectin-like. DR InterPro; IPR016186; C-type_lectin-like/link_sf. DR InterPro; IPR018378; C-type_lectin_CS. DR InterPro; IPR043315; CLEC9A. DR InterPro; IPR016187; CTDL_fold. DR InterPro; IPR033992; NKR-like_CTLD. DR PANTHER; PTHR47727; C-TYPE LECTIN DOMAIN FAMILY 9 MEMBER A; 1. DR PANTHER; PTHR47727:SF1; C-TYPE LECTIN DOMAIN FAMILY 9 MEMBER A; 1. DR Pfam; PF00059; Lectin_C; 1. DR SMART; SM00034; CLECT; 1. DR SUPFAM; SSF56436; C-type lectin-like; 1. DR PROSITE; PS00615; C_TYPE_LECTIN_1; 1. DR PROSITE; PS50041; C_TYPE_LECTIN_2; 1. PE 1: Evidence at protein level; KW 3D-structure; Disulfide bond; Endocytosis; Glycoprotein; Lectin; Membrane; KW Proteomics identification; Receptor; Reference proteome; Signal-anchor; KW Transmembrane; Transmembrane helix. FT CHAIN 1..241 FT /note="C-type lectin domain family 9 member A" FT /id="PRO_0000046637" FT TOPO_DOM 1..35 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 36..56 FT /note="Helical; Signal-anchor for type II membrane protein" FT /evidence="ECO:0000255" FT TOPO_DOM 57..241 FT /note="Extracellular" FT /evidence="ECO:0000255" FT DOMAIN 120..233 FT /note="C-type lectin" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00040" FT MOTIF 5..10 FT /note="ITAM-like" FT CARBOHYD 81 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 223 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 113..124 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00040, FT ECO:0000269|PubMed:22483802" FT DISULFID 141..232 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00040, FT ECO:0000269|PubMed:22483802" FT DISULFID 211..224 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00040, FT ECO:0000269|PubMed:22483802" FT VARIANT 107 FT /note="A -> G (in dbSNP:rs11831360)" FT /id="VAR_050112" FT MUTAGEN 131 FT /note="W->A: Abolishes binding to damaged cells; when FT associated with A-227." FT /evidence="ECO:0000269|PubMed:22483802" FT MUTAGEN 227 FT /note="W->A: Abolishes binding to damaged cells; when FT associated with A-131." FT /evidence="ECO:0000269|PubMed:22483802" FT STRAND 118..120 FT /evidence="ECO:0007829|PDB:3VPP" FT STRAND 123..127 FT /evidence="ECO:0007829|PDB:3VPP" FT HELIX 134..143 FT /evidence="ECO:0007829|PDB:3VPP" FT HELIX 154..164 FT /evidence="ECO:0007829|PDB:3VPP" FT STRAND 167..169 FT /evidence="ECO:0007829|PDB:3VPP" FT STRAND 172..179 FT /evidence="ECO:0007829|PDB:3VPP" FT TURN 181..183 FT /evidence="ECO:0007829|PDB:3VPP" FT STRAND 186..188 FT /evidence="ECO:0007829|PDB:3VPP" FT STRAND 210..215 FT /evidence="ECO:0007829|PDB:3VPP" FT STRAND 218..226 FT /evidence="ECO:0007829|PDB:3VPP" FT STRAND 228..235 FT /evidence="ECO:0007829|PDB:3VPP" SQ SEQUENCE 241 AA; 27324 MW; 6158B3AC44EEC9C3 CRC64; MHEEEIYTSL QWDSPAPDTY QKCLSSNKCS GACCLVMVIS CVFCMGLLTA SIFLGVKLLQ VSTIAMQQQE KLIQQERALL NFTEWKRSCA LQMKYCQAFM QNSLSSAHNS SPCPNNWIQN RESCYYVSEI WSIWHTSQEN CLKEGSTLLQ IESKEEMDFI TGSLRKIKGS YDYWVGLSQD GHSGRWLWQD GSSPSPGLLP AERSQSANQV CGYVKSNSLL SSNCSTWKYF ICEKYALRSS V //